✦ LIBER ✦

High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies

✍ Scribed by Kwong, Y-L

Book ID: 109840832
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 281 KB
Volume: 44
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2009.239

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant hematopoietic cell lines: in v

Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia–lymphoma

✍ Drexler, H G; Matsuo, Y 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Successful treatment of advanced natural

Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation

✍ Nawa, Y; Takenaka, K; Shinagawa, K; Deguchi, S; Matsumura, N; Koyama, S; Hiramat 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 32 KB

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience

✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C

Keratinocyte growth factor is effective

Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study

✍ Tsirigotis, P; Triantafyllou, K; Girkas, K; Giannopoulou, V; Ioannidou, E; Chond 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

Pharmacoeconomic evaluation of high-dose

Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignancies

✍ R. Kath; M. Hartmann; K. Höffken 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 202 KB

High-dose chemotherapy and autologous he

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years

✍ Mehta, J; Singhal, S 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 258 KB